CFMS

Conformis, Inc. (CFMS) | Rumor.io

Conformis

CFMS

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)—

Price to earnings ratio0

Market capitalization0

Earnings per share0

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)0

Social

What share of all stock conversation is about CFMS?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% new	0% new	0% 0

Jun 23

Conformis, Inc. ($CFMS) has announced a definitive agreement to be acquired by restor3d for $2.27 per share in cash.
The acquisition price of $2.27 per share is considered fair for investors who bought the stock in the last 2-3 months, but may be disappointing for those who bought earlier.
The acquisition is seen as a resolution to the company's struggles, which were attributed to poor management decisions and a lack of progress under CEO Mark Augusti.

Generated by AI

Sentiment

Of the messages about CFMS that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	100%
Bearish	—	—	—	0%

Bullish· Jun 23

Conformis, Inc. ($CFMS) has been acquired by restor3d, a leading personalized 3D-printed orthopedic company, for $2.27 per share in cash.
The acquisition is expected to be completed by the end of Q3 2023, with $CFMS shares climbing over 90% in the lead-up to the deal.
The combined entity is set to become a leading 3D-printed medical device company, with $CFMS shares trading at a 96% premium to their previous close.

Bearish· Aug 4

$CFMS is highly oversold, with big investors pushing it down to accumulate shares before a positive earnings announcement.
The COVID-19 pandemic has led to a decrease in elective surgeries worldwide, which could negatively impact Conformis' business.
$CFMS has a history of being a pump and dump stock, with a large increase in shares outstanding and a corresponding decrease in price.

Generated by AI

Topics

Of the messages about CFMS that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	—
Announcements	—	—	—	—
Controversies	—	—	—	—
Earnings	—	—	—	—
Macro	—	—	—	—
Technical Analysis	—	—	—	—

Earnings· May 2

Conformis, Inc. ($CFMS) reported FQ1 earnings of -$0.22 per share, beating the estimated loss of $0.25 per share.
The company's gross profit increased 45% year-over-year to $8.8 million in Q1.
Conformis, Inc. will host a Q1 earnings call on [date] at 4:30 PM Eastern to discuss its financial results.

Announcements· Jun 23

Conformis, Inc. ($CFMS) has entered into a definitive agreement to be acquired by restor3d for $2.27 per share in cash, representing a 96% premium to the closing price on June 22, 2023.
The acquisition is expected to create a leading personalized 3D-printed orthopedic medical device company, with restor3d purchasing all outstanding shares of Conformis.
The merger is subject to shareholder approval and other standard closing conditions, with an expected closing date by the end of Q3 2023.

Technical Analysis· Mar 21

$CFMS is in Wave C of Elliott Wave, with a target of $6 and a technical analysis date of 03/15/19 by Recognia.
$CFMS is oversold on the 1-minute RSI, likely to bounce soon.
$CFMS is overbought and needs to fill a gap down before it will climb back up.

Generated by AI

Community

Of the messages about CFMS, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	0%	0%	0%	0%
Newcomers	100%	100%	100%	100%

Regulars· Jun 23

Conformis, Inc. ($CFMS) has agreed to be acquired by restor3d for a purchase price of $2.27 per share in cash, representing a 96% premium to the previous closing price.
The acquisition deal has led to a significant surge in Conformis' stock price, with a ~90% increase.
The purchase price of $2.27 per share in cash is the consideration for the acquisition, which will result in an abrupt price boost for Conformis stock.

Newcomers· Jun 23

Conformis, Inc. ($CFMS) has announced a definitive agreement to be acquired by restor3d for $2.27 per share in cash, with the purchase price representing a significant increase over the current market value.
The company has seen a surge in pre-market trading, with its stock price rising over 90% and reaching $2.22.
Newcomers are taking notice of $CFMS, alongside $ONCS, as both stocks have made significant moves and are now being tracked for updates.

Generated by AI

Also Discussed

Investors talking about CFMS also mention

#	Name	Attention
1	Fuel Tech, Inc.FTEK	0%0
2	Grupo Supervielle S.A.SUPV	0%0
3	AVGR - Avinger, Inc.	——
4	Avalon Globocare CorpALBT	0%0
5	Orion Energy Systems, Inc.OESX	0%new
6	Alpha Metallurgical Resources, Inc.AMR	0%0
7	AZZ Inc.AZZ	0%0
8	Protara Therapeutics, Inc.TARA	0%0
9	Metallus Inc.MTUS	0.01%+0
10	TAIT - Taitron Components Incorporated	——

Conformis, Inc.

Location

Social

What share of all stock conversation is about CFMS?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% new	0% new	0% 0

Jun 23

Conformis, Inc. ($CFMS) has announced a definitive agreement to be acquired by restor3d for $2.27 per share in cash.
The acquisition price of $2.27 per share is considered fair for investors who bought the stock in the last 2-3 months, but may be disappointing for those who bought earlier.
The acquisition is seen as a resolution to the company's struggles, which were attributed to poor management decisions and a lack of progress under CEO Mark Augusti.

Generated by AI

Sentiment

Of the messages about CFMS that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	100%
Bearish	—	—	—	0%

Bullish· Jun 23

Conformis, Inc. ($CFMS) has been acquired by restor3d, a leading personalized 3D-printed orthopedic company, for $2.27 per share in cash.
The acquisition is expected to be completed by the end of Q3 2023, with $CFMS shares climbing over 90% in the lead-up to the deal.
The combined entity is set to become a leading 3D-printed medical device company, with $CFMS shares trading at a 96% premium to their previous close.

Bearish· Aug 4

$CFMS is highly oversold, with big investors pushing it down to accumulate shares before a positive earnings announcement.
The COVID-19 pandemic has led to a decrease in elective surgeries worldwide, which could negatively impact Conformis' business.
$CFMS has a history of being a pump and dump stock, with a large increase in shares outstanding and a corresponding decrease in price.

Generated by AI

Topics

Of the messages about CFMS that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	—
Announcements	—	—	—	—
Controversies	—	—	—	—
Earnings	—	—	—	—
Macro	—	—	—	—
Technical Analysis	—	—	—	—

Earnings· May 2

Conformis, Inc. ($CFMS) reported FQ1 earnings of -$0.22 per share, beating the estimated loss of $0.25 per share.
The company's gross profit increased 45% year-over-year to $8.8 million in Q1.
Conformis, Inc. will host a Q1 earnings call on [date] at 4:30 PM Eastern to discuss its financial results.

Announcements· Jun 23

Conformis, Inc. ($CFMS) has entered into a definitive agreement to be acquired by restor3d for $2.27 per share in cash, representing a 96% premium to the closing price on June 22, 2023.
The acquisition is expected to create a leading personalized 3D-printed orthopedic medical device company, with restor3d purchasing all outstanding shares of Conformis.
The merger is subject to shareholder approval and other standard closing conditions, with an expected closing date by the end of Q3 2023.

Technical Analysis· Mar 21

$CFMS is in Wave C of Elliott Wave, with a target of $6 and a technical analysis date of 03/15/19 by Recognia.
$CFMS is oversold on the 1-minute RSI, likely to bounce soon.
$CFMS is overbought and needs to fill a gap down before it will climb back up.

Generated by AI

Community

Of the messages about CFMS, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	0%	0%	0%	0%
Newcomers	100%	100%	100%	100%

Regulars· Jun 23

Conformis, Inc. ($CFMS) has agreed to be acquired by restor3d for a purchase price of $2.27 per share in cash, representing a 96% premium to the previous closing price.
The acquisition deal has led to a significant surge in Conformis' stock price, with a ~90% increase.
The purchase price of $2.27 per share in cash is the consideration for the acquisition, which will result in an abrupt price boost for Conformis stock.

Newcomers· Jun 23

Conformis, Inc. ($CFMS) has announced a definitive agreement to be acquired by restor3d for $2.27 per share in cash, with the purchase price representing a significant increase over the current market value.
The company has seen a surge in pre-market trading, with its stock price rising over 90% and reaching $2.22.
Newcomers are taking notice of $CFMS, alongside $ONCS, as both stocks have made significant moves and are now being tracked for updates.

Generated by AI

Conformis

Social

Jun 23

Sentiment

Bullish· Jun 23

Bearish· Aug 4

Topics

Earnings· May 2

Announcements· Jun 23

Technical Analysis· Mar 21

Community

Regulars· Jun 23

Newcomers· Jun 23

Also Discussed

Conformis, Inc.

Company Information

Location

Also Discussed

Social

Jun 23

Sentiment

Bullish· Jun 23

Bearish· Aug 4

Topics

Earnings· May 2

Announcements· Jun 23

Technical Analysis· Mar 21

Community

Regulars· Jun 23

Newcomers· Jun 23